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Introduction
Graft-versus-host disease (GVHD) is a serious complication after allogeneicstem cell transplantation(SCT). It is also a major cause of early and late morbidity and mortality in allogeneic SCT recipients [1] . Although the molecular pathogenesis of GVHD remains to be uncovered, there is a general agreement that infiltrating T lymphocytes play a central role and proinflammatory cytokines including IFN-γ,IL-6 and TNF-α are important mediators and regulators of GVHD [2, 3, 4] . After allogeneic SCT, vascular endothelial cells are the first allogeneic recipient cells encountered by circulating immunocompetent donor T cells. Host endothelial cells are a target of alloreactive donor cytotoxic T lymphocytes in GVHD [5, 6] . Vascular injury has been described in patients with acute and chronicGVHD. The markers of vascular injury including vWF, endothelial adhesion molecules (VCAM-1, E-selectin and ICAM-1), vascular growth factor, endothelial cell in circulation are proved to be highly related to GVHD [7, 8, 9] . Allogeneic T cell can induce tissue factor(TF) expression in vascular endothelial cell(VEC) [10, 11] . TF is a transmembrane protein present on the surface of activated cells and a member of the class II cytokine and hematopoietic growth factor receptor family [12] . Much recent data shows TF activity is important not only in coagulation-inflammation cycle, but also in regulating the release ofproinflammatory cytokines during the course of inflammation through intracellular signal transduction pathway. TF expression in VEC is upregulated post-injury and activation. And VEC is the main source of TF in vivo [13] . We postulate enhanced TF expression in VEC may play an pivotal role inthe pathogenesis of GVHD. To ascertain this speculation, we investigated TF mRNA and protein expression in organs of aGVHD mice and controls and theeffect of allogeneic T cells on TF,VCAM-1,TNF-α,IFN-γ and IL-6 expression and activation of MAPKs in HUVECs.
Materials and methods Mice
Eight-to 12-week-old female BALB/c(H2-K d ) and male C57BL/6 (H-2 b )
wild-type mice were purchased from Beijing Vital River Laboratory Animal Co.These studies were conducted in accordance with principles set forth in the and C57BL/6(allogeneic) donors on day 0 respectively. Mice were kept on antibiotic water (250 μg/ml erythromycin and 320 μg/ml gentamycin;) for the first 28 days and 5 days before transplantation. The survival and appearance of mice were monitored daily after SCT. Donor cell engraftment was determined by flow cytometric analysis of the percentage of H-2K b+ and H-2K d+ cells with the relevant monoclonal antibodies in the spleen cells on 14 days and 21 days after SCT. The degree of clinical GVHD was assessed bya scoring system described by Cooke et al [14] . that sums changes in five clinical parameters: weight loss, posture, activity, fur texture and skin integrity (maximum index=10).
The allogeneic SCT mice were killed when they showed typical GVHD signs(GVHD score≥8), syngeneic SCT mice were killed 3 or 4 weeks after SCT, and the ear skin, liver, small intestine, stomach, lung, kidney were subjectedto histopathological examination, quantitative real-time PCR and Western blotting analysis.
Histologic examination
The organs were fixed with 4% neutral buffered formalin, and embedded in paraffin. After the thin tissue sections had been deparaffinized on glass slides, samples were stained with hematoxylin and eosin.
Cell isolation and cell cultures
Human peripheral blood mononuclear cells(PBMC) were separated from healthy volunteers using Ficoll-Hypaque gradients. T cells were added to HUVECs(ratio 10:1). The cells were grown at 37 in a humidified atmosphere containing 5% CO 2 . To detect the effect of TF antibody, SB203580(inhibitor of p38MAPK), SP600125(inhibitor of JNK) on allogeneic T cell-induced HUVECs, HUVECs were pretreated with TF antibody(20μg/ml), SB203580(10μM), SP600125(30μM) seperatedly 30 minutes before coculturing.
Measurements of TF and VCAM-1 expression on HUVEC membrane by flowcytometry
After coculturing with allogeneic CD4+T cells or CD8+T cells for 0,3,6,12hours, HUVECs were removed from the wells with non-enzymatic Cellstripper after being washed with cold PBS, and labeled with FITC-TF, FITC-VCAM-1,FITC-IgG 2a respectively according to manufacturer's instructions. The percentageof TF and VCAM-1 expression was analyzed by flowcytometry.
Quantitative real-time PCR
Freshly isolated organs(n =10) were snap-frozen in liquid nitrogen and stored at -80 until total RNA extraction. Total RNA of the organs and HUVECs was extracted by using TRIzol reagent according to the protocol provided bythe manufacturer. Two micrograms of total RNA each probe were reverse transcribed to single-strand cDNA using oligo(dT) primer and 20 U MMLV.
Quantitative real-time PCR was then used to detect TF mRNA in organs of aGVHD mice and the controls. TF, TNF-α, IFN-γ, IL-6 mRNA of HUVECswas also detected. With 2.5μl of cDNA being incubated in 25μl IQ Supermix containing 500nM of respective primers, or 50nM of 18S primers used for sample normalization, and fluorescence dye SYBR Green Ⅰ. The sequence of primers and condition of real-time PCR was given in table 1. The specificity of the amplified products was monitoredby means of melting curves at the end of each amplification. Real-time RT-PCR was carried out in triplicate for each sample using a 7500 Real-Time PCR System(Applied Biosystems, Foster City, CA, USA).
Assessments of TF expression in the organs and MAPKs activation of HUVEC by Western blotting
After coculturing with allogeneic CD4 + T cells or CD8 + T cells for 0,15,30,60 minutes, HUVECs were lysed with nonionic detergent-containing buffer, the lysed cells were scraped off the dish using a rubber policeman, the tissues were also lysed with nonionic detergent-containing buffer, then transferred to microcentrifuge tubes, and vortexed for 10 s. The cell and tissue lysates were centrifuged to remove insoluble materials and the protein concentration of each sample was measured. Approximately 50μg of supernatant protein from each samplewas used for gel electrophoresis analysis on a 10% SDS-polyacrylamide gel. After electrophoresis, the fractionated proteins on gel were transferred to PVDF membranes. After blocking with 5% milk overnight, the membrane was incubated overnight with the primary antibody separately, then the membranes were extensively washed with TBST and incubated for 60 min with the secondary antibody. After extensive washing with TBST, the immune complexes were detected by ECL kit (Pierce Biotechnology,USA).
Statistical analysis
Data are shown as means±SD of three independent experiments. Data were analyzed by two-way analysis of variances(ANOVA) using the Statistical Analysis System(SAS, Cary, NC). A P-value less than 0.05 was considered significant.
Results
The manifestation of aGVHD after allogeneic SCT Allogeneic SCT mice showed typical symptoms of aGVHD such as weightloss, diarrhea, dermal ulcer, depilate and posture change during 18~28 days after SCT and all died in the first 28 days after SCT. Typical histologic changesof aGVHD were seen in liver, skin, stomach, small intestine of them. On 14 days and 21 days after SCT flowcytometric assay demonstrated over 95% spleencells of allogeneic SCT mice were from donors. It verified successful implantation of donor hematopoietic stem cells. But there was no clinical and hitologic appearance of aGVHD in the controls.
Upregulation of TF mRNA and protein expression in target organs of aGVHD
Enhanced TF mRNA expression were seen in the skin, stomach, small intestine, liver of aGVHD mice(p<0.001), they were respectively 15.1±2.1，5.5±1.4，9.7±2.3，
14.3±2.9 times higher than controls. There were no difference in the TF mRNA expression of the lung and kidney between the two groups(figure 1). The results of TF protein expression tested by Western blotting were inaccord with the results of quantitative real-time PCR(figure 2). Protein expression of TF in skin,stomach,small intestine,liver of aGVHD mice were respectively 6.1±3.1, 7.2±2.5，8.7±2.3, 10.7±4.9 times higher than the controls(P<0.01).
Allogeneic CD4 + T cells and CD8 + T cells enhance TF, VCAM-1, TNF-α, IFN-γ,

IL-4 expression in HUVECs
Flowcytometric assay showed TF、VCAM-1 expression on TNF-α pretreated HUVEC membrane are very low. After incubated with allogeneic CD4 + T cells or CD8 + T cells, TF and VCAM-1 expression on HUVEC membrane increased significantly(p<0.01), and reached peak value at the 6-h time-point(showed in table 2,3).
After coculturing with allogeneic CD4 + T cells or CD8 + T cells for 3,6,12 hours, TF mRNA expression in HUVECs was elevated significantly and reachedpeak value at the 3-h time-point; TNF-α,IFN-γ,IL-6 mRNA expression also wasupregulated, and reached the peak value at the 6-h time-point(figure 3). 
Involvement of MAPKs in allogeneic CD4 + T cells and CD8 + T cells-inducedTF expression in HUVECs
The effect of monoclonal antibody against TF, SB203580, SP600125 on allogeneic T cells-induced cytokines expression of HUVECs
Mice anti-human TF monoclonal antibody(American Diagnostica Inc.) is the neutralizing antibody of TF [15] . HUVECs were pretreated with TF antibody, SP600125, SB203580 30 minutes before stimulation with T cells. At t=6h, allogeneic T cells-induced VCAM-1 expression on HUVECs membrane was decreased compared with non-treated HUVEC (Table 4) , allogeneic T cells-induced TNF-α, IFN-γ, IL-6 mRNA expression in HUVECs was also downregulated by TF antibody, SB203580, SP600125 compared with non-treated HUVECs( Figure 5) .
Discussion
In the present study, a model of murine aGVHD after allogeneic SCT was established. To exclude the influence of conditioning regimen, syngeneic SCTmice were used as controls. TF mRNA and protein expression were enhanced specifically in target organs of GVHD including skin, liver, stomach, smallintestine. These data indicates that upregulation of TF expression is related to tissue damage caused by GVHD. Because there are abundant vascular beds in these organs, and TF expression of VECs upregulates post injury and activation, we postulate that upregulated TF expression of VEC may contribute to tissue injury caused by GVHD.
To verify this speculation, we cocultured allogeneic CD4 Much research of recent years provide the evidence that TF is involved in transplant immunology. Naji,et al [16] pointed out that donor specific antibody can induce TF overexpression in VEC. Schmid,et al [11] reportted that after coculturingwith allogeneic CD4 + T cells and CD8 + T cells, TF mRNA and protein expression in VEC increased significantly. Significantly higher levels of microparticles (containing TF) from endothelial cells were observed in patients with acute GVHD, in contrast, neither the conditioning regimen nor infectious complications influenced the level of these microparticles [17] . It is clearly explicated that VCAM-1 expression in target organs of GVHD increased and enhanced expression of VCAM-1 is correlated to donor T cellinfiltration [18] . Much data shows TNF-α，IFN-γ, IL-6 are important markers of GVHD [19] . Enhanced TF expression in VEC is induced by proinflammatory cytokines that are secreted by T cells, which in turn contribute to cytokine generation or inflammatory cell apoptosis through intracelluar signal transduction [12, 20, 21] . So allogeneic T cells-induced TF and consecutive proinflammatory cytokinesexpression in VEC may contribute to the pathogenesis of GVHD. TF is the key factor in GVHD mediated by VEC, measures which block TF expression inVEC may inhibit production of proinflammatory cytokines and donor T cells infiltration contributing to GVHD and alleviate GVHD. Furthermore, there is increasing evidence of the existence of an endothelial form of graft-versus-host disease, VEC injury is closely related to tissue damage caused by GVHD [22] ，measures to ameliorate VEC injury may separate GVHD from the beneficial graft-versus-leukaemia effect.
The mitogen-activated protein kinases (MAPKs), play an essential role in regulating several intracellular processes, such as gene expression, growth, cell survival, differentiation or death [23, 24] .To further explore the mechanisms of allogeneic T cells-induced TF expression in HUVECs, Western blotting was applied to measure the phosphorylation of three members of the MAPK family (ERK, JNK, p38 MAPK). Our results demonstrate that allogeneic T cells activate the phosphorylation of JNK and p38MAPK, and inhibition of p38 MAPK and JNK,significantly prevent allogeneic T cells-induced TF, VCAM-1 and proinflammatory cytokines expression. These data suggest targeting JNK and p38MAPK pathway may be valuable in designing new therapy modalities for treating GVHD.
In conclusion, this preliminary study indicates that enhanced TF expressionof VEC plays an important role in the pathogenesis of tissue damage caused by GVHD, and measures to block TF expression in VEC including monoclonal antibody against TF, inhibitor of p38MAPK and JNK can interrupt TF mediated inflammation, thus may ameliorate GVHD. These data lead to better understanding of the mechanisms of GVHD and may provide a new target for treatment of GVHD. 
